Your browser doesn't support javascript.
loading
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Naqash, Abdul Rafeh; Ricciuti, Biagio; Owen, Dwight H; Florou, Vaia; Toi, Yukihiro; Cherry, Cynthia; Hafiz, Maida; De Giglio, Andrea; Muzaffar, Mavish; Patel, Sandip H; Sugawara, Shunichi; Burkart, Jarred; Park, Wungki; Chiari, Rita; Sugisaka, Jun; Otterson, Gregory A; de Lima Lopes, Gilberto; Walker, Paul R.
Afiliación
  • Naqash AR; Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bldg 31/3A44, 31 Centre Drive, Bethesda, MD, 20892, USA. abdulrafeh.naqash@nih.gov.
  • Ricciuti B; Division of Hematology/Oncology, Department of Internal Medicine, East Carolina University, Greenville, NC, USA. abdulrafeh.naqash@nih.gov.
  • Owen DH; Thoracic Oncology Unit, Santa Maria Della Misericordia Hospital, University of Perugia, Perugia, Italy.
  • Florou V; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Toi Y; Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA.
  • Cherry C; Division of Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Hafiz M; Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • De Giglio A; Department of Pulmonary Medicine, Sendai Kousei Hospital, Hirosemachi, Aoba-Ku, Sendai, Japan.
  • Muzaffar M; Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bldg 31/3A44, 31 Centre Drive, Bethesda, MD, 20892, USA.
  • Patel SH; Division of Hematology/Oncology, Department of Internal Medicine, East Carolina University, Greenville, NC, USA.
  • Sugawara S; Department of Pulmonary Medicine, East Carolina University, Greenville, NC, USA.
  • Burkart J; Thoracic Oncology Unit, Santa Maria Della Misericordia Hospital, University of Perugia, Perugia, Italy.
  • Park W; Division of Hematology/Oncology, Department of Internal Medicine, East Carolina University, Greenville, NC, USA.
  • Chiari R; Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA.
  • Sugisaka J; Department of Pulmonary Medicine, Sendai Kousei Hospital, Hirosemachi, Aoba-Ku, Sendai, Japan.
  • Otterson GA; Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA.
  • de Lima Lopes G; Division of Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Walker PR; Memorial Sloan Kettering Cancer Center, New York, USA.
Cancer Immunol Immunother ; 69(7): 1189, 2020 07.
Article en En | MEDLINE | ID: mdl-32347358

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos